New Combinations of Mutations in VanD-Type Vancomycin-Resistant Enterococcus faecium , Enterococcus faecalis , and Enterococcus avium Strains

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

We studied the clinical isolates Enterococcus faecium NEF1, resistant to high levels of vancomycin (MIC, 512 microg/ml) and teicoplanin (MIC, 64 microg/ml); Enterococcus faecium BM4653 and BM4656 and Enterococcus avium BM4655, resistant to moderate levels of vancomycin (MIC, 32 microg/ml) and to low levels of teicoplanin (MIC, 4 microg/ml); and Enterococcus faecalis BM4654, moderately resistant to vancomycin (MIC, 16 microg/ml) but susceptible to teicoplanin (MIC, 0.5 microg/ml). The strains were distinct, were constitutively resistant via the synthesis of peptidoglycan precursors ending in D-alanyl-D-lactate, and harbored a chromosomal vanD gene cluster that was not transferable. New mutations were found in conserved domains of VanS(D): at T(170)I near the phosphorylation site in NEF1, at V(67)A at the membrane surface in BM4653, at G(340)S in the G2 ATP-binding domain in BM4655, in the F domain in BM4656 (a 6-bp insertion), and in the G1 and G2 domains of BM4654 (three mutations). The mutations resulted in constitutivity, presumably through the loss of the phosphatase activity of the sensor. The chromosomal Ddl D-Ala:D-Ala ligase had an IS19 copy in NEF1, a mutation in the serine (S(185)F) or near the arginine (T(289)P) involved in D-Ala1 binding in BM4653 or BM4655, respectively, and a mutation next to the lysine (P(180)S) involved in D-Ala2 binding in BM4654, leading to the production of an impaired enzyme. In BM4653 vanY(D), a new insertion sequence, ISEfa9, belonging to the IS3 family, resulted in the absence of D,D-carboxypeptidase activity. Strain BM4656 had a functional D-Ala:D-Ala ligase, associated with high levels of both VanX(D) and VanY(D) activities, and is the first example of a VanD-type strain with a functional Ddl enzyme. Study of these five clinical isolates, displaying various assortments of mutations, confirms that all VanD-type strains isolated so far have undergone mutations in the vanS(D) or vanR(D) gene, leading to constitutive resistance, but that the Ddl host ligase is not always impaired. Based on sequence differences, the vanD gene clusters could be assigned to two subtypes: vanD-1 and vanD-4.

Knowledge Graph

Similar Paper

New Combinations of Mutations in VanD-Type Vancomycin-Resistant Enterococcus faecium , Enterococcus faecalis , and Enterococcus avium Strains
Antimicrobial Agents and Chemotherapy 2009.0
VanB-Type Enterococcus faecium Clinical Isolate Successively Inducibly Resistant to, Dependent on, and Constitutively Resistant to Vancomycin
Antimicrobial Agents and Chemotherapy 2009.0
vanM , a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium
Antimicrobial Agents and Chemotherapy 2010.0
vanD and vanG -Like Gene Clusters in a Ruminococcus Species Isolated from Human Bowel Flora
Antimicrobial Agents and Chemotherapy 2007.0
Novel Mechanism of Glycopeptide Resistance in the A40926 Producer Nonomuraea sp. ATCC 39727
Antimicrobial Agents and Chemotherapy 2010.0
Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin
Antimicrobial Agents and Chemotherapy 2010.0
Characterization of Two Newly Identified Genes, vgaD and vatG , Conferring Resistance to Streptogramin A in Enterococcus faecium
Antimicrobial Agents and Chemotherapy 2010.0
VanA-Type Vancomycin-ResistantStaphylococcus aureus
Antimicrobial Agents and Chemotherapy 2009.0
Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus
Antimicrobial Agents and Chemotherapy 2008.0
Isolation of VanB-Type Enterococcus faecalis Strains from Nosocomial Infections: First Report of the Isolation and Identification of the Pheromone-Responsive Plasmids pMG2200, Encoding VanB-Type Vancomycin Resistance and a Bac41-Type Bacteriocin, and pMG2201, Encoding Erythromycin Resistance and Cytolysin (Hly/Bac)
Antimicrobial Agents and Chemotherapy 2009.0